<SEC-DOCUMENT>0001558370-20-003529-index.html : 20200401
<SEC-HEADER>0001558370-20-003529.hdr.sgml : 20200401
<ACCEPTANCE-DATETIME>20200401171853
ACCESSION NUMBER:		0001558370-20-003529
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20200401
DATE AS OF CHANGE:		20200401
EFFECTIVENESS DATE:		20200401

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeuroBo Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-237535
		FILM NUMBER:		20766392

	BUSINESS ADDRESS:	
		STREET 1:		200 BERKELEY ST.
		STREET 2:		FL 19
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		(857) 702-9600

	MAIL ADDRESS:	
		STREET 1:		200 BERKELEY ST.
		STREET 2:		FL 19
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
		DATE OF NAME CHANGE:	20150331
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>s-8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: s-8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex-5d1.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: ex-5d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex-23d1.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: ex-23d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>4
<FILENAME>ex-24d1.htm
<DESCRIPTION>EX-24.1
<TEXT>
Document 4 - file: ex-24d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex-5d1g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: ex-5d1g001.jpg

</DOCUMENT>
</SEC-DOCUMENT>